Dr Lal PathLabs raises Rs 191 cr from investors

Dr Lal PathLabs raises Rs 191 cr from investors

FPJ BureauUpdated: Friday, May 31, 2019, 08:13 PM IST
article-image

New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.

Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.

At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.

RECENT STORIES

Indian Officials To Visit US Next Week To Finalise Text For Interim Trade Agreement
Indian Officials To Visit US Next Week To Finalise Text For Interim Trade Agreement
MMRDA Presents ₹48,072 Crore Surplus Budget For 2026–27, Marks First Positive Turn Since...
MMRDA Presents ₹48,072 Crore Surplus Budget For 2026–27, Marks First Positive Turn Since...
Better Seats, More Flights: Air India Details 2026 Upgrades For London, Toronto, And Melbourne
Better Seats, More Flights: Air India Details 2026 Upgrades For London, Toronto, And Melbourne
ED Files Chargesheet In ₹61,700 Crore Videocon Bank Fraud, Delhi Court Issues Notices To Dhoot
ED Files Chargesheet In ₹61,700 Crore Videocon Bank Fraud, Delhi Court Issues Notices To Dhoot
Investors May Lift Equity Exposure To 60–65 Per Cent As Medium-Term Market Outlook Strengthens: PL...
Investors May Lift Equity Exposure To 60–65 Per Cent As Medium-Term Market Outlook Strengthens: PL...